These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8096246)

  • 1. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP; Collins N; Lung FD; Davis P; Zalewska T; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1994 Nov; 37(23):3910-7. PubMed ID: 7966152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.
    Kawasaki AM; Knapp RJ; Walton A; Wire WS; Zalewska T; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    Int J Pept Protein Res; 1993 Nov; 42(5):411-9. PubMed ID: 7906258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
    Lemaire S; Turcotte A
    Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of potent and selective dynorphin A related peptides devoid of supraspinal motor effects in mice.
    Shukla VK; Lemaire S; Ibrahim IH; Cyr TD; Chen Y; Michelot R
    Can J Physiol Pharmacol; 1993; 71(3-4):211-6. PubMed ID: 8104674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
    J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2.
    Yoshino H; Arakawa Y; Nakazawa T; Kaneko T; Matsunaga M; Araki S; Ikeda M; Tsuchiya Y; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2274-6. PubMed ID: 1980641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity.
    Collins N; Hruby VJ
    Biopolymers; 1994 Sep; 34(9):1231-41. PubMed ID: 7948735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.
    Lemaire S; Lafrance L; Dumont M
    Int J Pept Protein Res; 1986 Mar; 27(3):300-5. PubMed ID: 2872177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.